HCA Healthcare, Inc. $HCA Shares Sold by Credit Agricole S A

Key Points

• Credit Agricole S A reduced its stake in HCA Healthcare by 8.8%, now holding 66,121 shares worth approximately $22.85 million.
• HCA Healthcare beat analysts' earnings expectations with a quarterly EPS of $6.84 and reported revenues of $18.61 billion, a 6.4% increase year-over-year.
• The company declared a quarterly dividend of $0.72 per share, representing an annual yield of 0.7%, with an ex-dividend date set for September 16.

Credit Agricole S A trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 8.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 66,121 shares of the company's stock after selling 6,415 shares during the period. Credit Agricole S A's holdings in HCA Healthcare were worth $22,848,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently made changes to their positions in the company. Cheviot Value Management LLC bought a new stake in HCA Healthcare in the first quarter worth about $26,000. Atwood & Palmer Inc. bought a new position in shares of HCA Healthcare during the first quarter valued at approximately $28,000. Bartlett & CO. Wealth Management LLC boosted its stake in shares of HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after purchasing an additional 80 shares in the last quarter. ORG Partners LLC boosted its stake in shares of HCA Healthcare by 344.0% during the first quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after purchasing an additional 86 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. lifted its position in HCA Healthcare by 75.8% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock valued at $40,000 after acquiring an additional 50 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Analysts Set New Price Targets

HCA has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. upped their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. Royal Bank Of Canada dropped their price objective on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a report on Monday, July 28th. Wolfe Research downgraded shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Finally, Morgan Stanley decreased their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research note on Monday, July 28th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $398.58.

HCA Healthcare Trading Up 0.2%

Shares of HCA traded up $0.61 during trading on Friday, reaching $404.87. 1,081,188 shares of the company traded hands, compared to its average volume of 1,431,386. The stock has a market cap of $94.74 billion, a PE ratio of 17.02, a price-to-earnings-growth ratio of 1.27 and a beta of 1.39. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. The stock has a 50-day simple moving average of $373.91 and a 200-day simple moving average of $354.02. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business's quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the business posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is currently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.